» Articles » PMID: 35356372

Prevalence of Non-alcoholic Fatty Liver Disease Among Patients with Diabetes Mellitus Attending Primary Health Care Centers in Bahrain

Overview
Journal Oman Med J
Specialty General Medicine
Date 2022 Mar 31
PMID 35356372
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To identify the prevalence of non-alcoholic fatty liver disease (NAFLD) among patients with type 2 diabetes mellitus (T2DM) in Bahrain and to assess the risk factors for the same.

Methods: This retrospective cross-sectional study investigated a random sample of patients who were treated for T2DM during 2018 at non-communicable disease clinics in primary health centers in Bahrain. Cases of 382 patients who underwent abdominal ultrasonography were selected for the study. The collected patients' data were statistically analyzed. Prevalence of NAFLD among T2DM patients and the possible risk factors were assessed.

Results: The mean age of the study population (N = 382) was 59.0±12.0 years. The majority (61.5%) were women. Hypertension (57.9%) was the most prevalent associated condition. Most patients were either overweight (30.5%) or obese (58.3%). Fatty liver was found in 68.1% patients based on ultrasound imaging. Elevated alanine aminotransferase was found in 75 (21.0%) out of 357 (93.5%) patients who were tested for the same. The significant risk factors identified for fatty liver were female ( = 0.013), high body mass index (BMI) ( 0.001), high waist circumference ( = 0.011), and high triglyceride levels ( = 0.043). Binary logistic regression identified BMI as an independent risk factor for fatty liver ( = 0.005).

Conclusions: The prevalence of NAFLD among patients with T2DM in Bahrain is high, and comparable to the levels reported in other studies. Female and high BMI, waist circumference, and triglyceride level are risk factors for NAFLD, while BMI is an independent risk factor.

Citing Articles

Multipronged Approach to Assess Risk Factors for Non-alcoholic Fatty Liver Disease.

Hidrus A, Tung S, Syed Abdul Rahim S, Hayati F Oman Med J. 2022; 37(5):e425.

PMID: 36188884 PMC: 9464331. DOI: 10.5001/omj.2022.93.

References
1.
Williamson R, Price J, Glancy S, Perry E, Nee L, Hayes P . Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care. 2011; 34(5):1139-44. PMC: 3114489. DOI: 10.2337/dc10-2229. View

2.
Talwalkar P, Deshmukh V, Bhole M . Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India: a cross-sectional observational study. Diabetes Metab Syndr Obes. 2019; 12:369-376. PMC: 6431000. DOI: 10.2147/DMSO.S181470. View

3.
Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84. DOI: 10.1002/hep.28431. View

4.
Younossi Z, Anstee Q, Marietti M, Hardy T, Henry L, Eslam M . Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2017; 15(1):11-20. DOI: 10.1038/nrgastro.2017.109. View

5.
Rinella M . Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015; 313(22):2263-73. DOI: 10.1001/jama.2015.5370. View